Chase Sun has been actively facilitating endogenous growth, epitaxial expansion and integrated development based on the core pharmaceutical and healthcare business through innovative R&D and capital-driven growth. The company is dedicated to becoming an excellent big health industry service provider, building health related ecosystem, and facilitating sustainable development of society.
Innovative R&D · Capital-driven growth
Chase Sun has increased R&D input, built innovation and R&D system, realized deployments of series varieties in key areas and reserve of gradient product group through capital-driven growth and integration of resources, and built a big health industry cluster to enable sustainable operation of the company.
People orientation · Integrated medical and health care
Being people-oriented and patient health-focused, Chase Sun has been taking reduction of China’s ICU fatality rate as its own responsibility, focusing on continuous exploration of the five drug areas of critical, neoplastic, cardio-cerebrovascular, respiratory and neurodegenerative diseases, and developing innovative product mix. Meanwhile, the business has realized on campus and out campus whole process management of private doctors through the trinity of off-line physical clinics, on-line diagnosis and treatment platform and powerful medical resources of TCM practitioners, offered six-dimensional full course diagnosis and treatment of ‘drug · diet · exercise · meditation · rehabilitation · knowledge’ , provided each user with personalized and precise healthcare solution, and realized sustainable development of products and services.
